|
|||||
|
|
Phase I Trial of Motexafin Gadolinium in Combination with Docetaxel and Cisplatin for the Treatment of Non-small Cell Lung Cancer |
|
| Institution: | 2. Pharmacyclics Inc., Sunnyvale, California |
| Abstract: | |
| Keywords: | Motexafin gadolinium Cisplatin Docetaxel Non-small cell lung cancer |
| 本文献已被 ScienceDirect 等数据库收录！ | |